Crossingbridge Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
Crossingbridge Advisors's TDAC Position: Q2 2026 in Review
Crossingbridge Advisors sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 290,100 shares — an estimated $3.06M sold.
Crossingbridge Advisors first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $5.9M in Q1 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.
- Crossingbridge Advisors reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
- Crossingbridge Advisors sold 290,100 Translational Development Acquisition Corp shares in Q2 2026, an estimated $3.06M.
- Crossingbridge Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
- Crossingbridge Advisors's Translational Development Acquisition Corp position peaked at $5.9M in Q1 2025.
- 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.
Based on Crossingbridge Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.